Market Cap N/A
Revenue (ttm) 29.62M
Net Income (ttm) -47.58M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -160.63%
Debt to Equity Ratio N/A
Volume 18,900
Avg Vol 36,610
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 58%
Beta N/A
Analysts Sell
Price Target $43.00
Latest News on KYNB
FibroGen, Inc. (FGEN) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 10:01 PM EST - 2 months ago

FibroGen, Inc. (FGEN) Q3 2025 Earnings Call Transcript


FibroGen to Report Third Quarter 2025 Financial Results

Nov 3, 2025, 4:02 PM EST - 2 months ago

FibroGen to Report Third Quarter 2025 Financial Results


FibroGen, Inc. (FGEN) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 11:55 PM EDT - 5 months ago

FibroGen, Inc. (FGEN) Q2 2025 Earnings Call Transcript


FibroGen to Report Second Quarter 2025 Financial Results

Aug 4, 2025, 4:02 PM EDT - 5 months ago

FibroGen to Report Second Quarter 2025 Financial Results


FibroGen Announces 1-for-25 Reverse Stock Split

Jun 12, 2025, 4:02 PM EDT - 7 months ago

FibroGen Announces 1-for-25 Reverse Stock Split


FibroGen, Inc. (FGEN) Q1 2025 Earnings Call Transcript

May 12, 2025, 10:31 PM EDT - 8 months ago

FibroGen, Inc. (FGEN) Q1 2025 Earnings Call Transcript


FibroGen to Report First Quarter 2025 Financial Results

May 5, 2025, 4:05 PM EDT - 8 months ago

FibroGen to Report First Quarter 2025 Financial Results


FibroGen, Inc. (FGEN) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 8:18 PM EDT - 10 months ago

FibroGen, Inc. (FGEN) Q4 2024 Earnings Call Transcript


FibroGen Appoints David DeLucia as Chief Financial Officer

Dec 16, 2024, 8:05 AM EST - 1 year ago

FibroGen Appoints David DeLucia as Chief Financial Officer


FibroGen Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 4:05 PM EST - 1 year ago

FibroGen Reports Third Quarter 2024 Financial Results


FibroGen to Report Third Quarter 2024 Financial Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

FibroGen to Report Third Quarter 2024 Financial Results


FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 11:32 AM EDT - 1 year ago

FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript


FibroGen to Report Second Quarter 2024 Financial Results

Jul 30, 2024, 4:07 PM EDT - 1 year ago

FibroGen to Report Second Quarter 2024 Financial Results


FibroGen to Participate in Upcoming Investor Conferences

May 7, 2024, 7:00 AM EDT - 1 year ago

FibroGen to Participate in Upcoming Investor Conferences


FibroGen, Inc. (FGEN) Q1 2024 Earnings Call Transcript

May 6, 2024, 10:31 PM EDT - 1 year ago

FibroGen, Inc. (FGEN) Q1 2024 Earnings Call Transcript


FibroGen Reports First Quarter 2024 Financial Results

May 6, 2024, 4:02 PM EDT - 1 year ago

FibroGen Reports First Quarter 2024 Financial Results


FibroGen to Report First Quarter 2024 Financial Results

Apr 29, 2024, 7:00 AM EDT - 1 year ago

FibroGen to Report First Quarter 2024 Financial Results


FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer

Mar 11, 2024, 7:00 AM EDT - 1 year ago

FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer


FibroGen, Inc. (FGEN) Q4 2023 Earnings Call Transcript

Feb 26, 2024, 11:44 PM EST - 2 years ago

FibroGen, Inc. (FGEN) Q4 2023 Earnings Call Transcript


FibroGen regains rights to anemia drug from AstraZeneca

Feb 26, 2024, 4:18 PM EST - 2 years ago

FibroGen regains rights to anemia drug from AstraZeneca

AZN